Front Row Advisors’s Bayer BAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-437
Closed -$6K – 948
2022
Q2
$6K Hold
437
– – ﹤0.01% 650
2022
Q1
$7K Buy
+437
New +$7K ﹤0.01% 651
2021
Q1
– Sell
-781
Closed -$12K – 986
2020
Q4
$12K Hold
781
– – 0.01% 484
2020
Q3
$12K Sell
781
-198
-20% -$3.04K 0.01% 476
2020
Q2
$18K Buy
979
+102
+12% +$1.88K 0.01% 366
2020
Q1
$14K Buy
877
+303
+53% +$4.84K 0.01% 403
2019
Q4
$12K Hold
574
– – 0.01% 432
2019
Q3
$10K Sell
574
-3
-0.5% -$52 0.01% 449
2019
Q2
$10K Sell
577
-330
-36% -$5.72K 0.01% 444
2019
Q1
$15K Buy
907
+569
+168% +$9.41K 0.01% 383
2018
Q4
$6K Buy
+338
New +$6K 0.01% 517

Other funds holding BAY

Front Row Advisors's BAY Position: Q3 2022 in Review

Front Row Advisors sold out of Bayer (BAY) in Q3 2022, closing a stake of 437 shares — an estimated $6K sold.

Front Row Advisors first reported a position in BAY in Q4 2018 and held it in 11 quarters. The position peaked at $18K in Q2 2020. 15 funds tracked by Wall St. Rank hold BAY as of Q3 2022.

  • Front Row Advisors reported no remaining Bayer position as of Q3 2022 after selling out during the quarter.
  • Front Row Advisors sold 437 Bayer shares in Q3 2022, an estimated $6K.
  • Front Row Advisors first reported a position in Bayer in Q4 2018 and held it in 11 quarters.
  • Front Row Advisors's Bayer position peaked at $18K in Q2 2020.
  • 15 funds tracked by Wall St. Rank held Bayer as of Q3 2022.

Based on Front Row Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.